Published in Arch Int Pharmacodyn Ther on January 01, 1986
Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit. Br J Pharmacol (1990) 1.01
The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease. J Hypertens Suppl (1997) 0.92
Influence of anaesthesia on the cardiovascular effects of rilmenidine and clonidine in spontaneously hypertensive rats. Br J Pharmacol (1992) 0.80
Comparative effects of rilmenidine and clonidine on bronchial responses to histamine in asthmatic subjects. Br J Clin Pharmacol (1988) 0.78
Pharmacogenetics: from bench to byte--an update of guidelines. Clin Pharmacol Ther (2011) 3.36
Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors. J Pharmacol Exp Ther (1987) 1.85
Postsynaptic alpha 1- and alpha 2-adrenoceptors in the circulatory system of the pithed rat: selective stimulation of the alpha 2-type by B-HT 933. Eur J Pharmacol (1980) 1.75
Prazosin and its analogues UK-18,596 and UK-33,274: a comparative study on cardiovascular effects and alpha-adrenoceptor blocking activities. Arch Int Pharmacodyn Ther (1980) 1.69
A comparison of the accumulation and release of 3H-ouabain and 3H-digitoxin by guinea-pig heart muscle. Br J Pharmacol Chemother (1968) 1.62
Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther (1990) 1.60
Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther (1990) 1.57
The central action of antihypertensive drugs, mediated via central alpha-receptors. J Pharm Pharmacol (1973) 1.56
Accumulation and release of 3H-digoxin by guinea-pig heart muscle. Br J Pharmacol Chemother (1967) 1.55
Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). J Pharmacol Exp Ther (1990) 1.50
Early scintigraphic detection of experimental myocardial infarction in dogs with technetium-99m-glucaric acid. J Nucl Med (1991) 1.50
Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research. Hypertension (1991) 1.48
Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther (1990) 1.46
Pharmacogenetics: from bench to byte. Clin Pharmacol Ther (2008) 1.40
alpha 2 adrenoceptors: classification, localization, mechanisms, and targets for drugs. J Med Chem (1982) 1.38
Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats. J Pharmacol Exp Ther (1982) 1.38
Selectivity of some alpha adrenoceptor agonists for peripheral alpha-1 and alpha-2 adrenoceptors in the normotensive rat. J Pharmacol Exp Ther (1981) 1.35
Vascular smooth muscle contraction initiated by postsynaptic alpha 2-adrenoceptor activation is induced by an influx of extracellular calcium. Eur J Pharmacol (1981) 1.33
Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors. Proc Natl Acad Sci U S A (1999) 1.33
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy. J Med Chem (1996) 1.32
Mini-review. The postsynaptic alpha 2-adrenoreceptor. J Auton Pharmacol (1981) 1.32
Comparison between the acute hemodynamic effects and brain penetration of atenolol and metoprolol. J Cardiovasc Pharmacol (1980) 1.29
Possible subdivision of postsynaptic alpha-adrenoceptors mediating pressor responses in the pithed rat. Naunyn Schmiedebergs Arch Pharmacol (1979) 1.23
Postsynaptic alpha 1- and alpha 2-adrenoceptors in human blood vessels: interactions with exogenous and endogenous catecholamines. Eur J Clin Invest (1987) 1.21
The kinetic behaviour of cardiac glycosides in vivo, measured by isotope techniques. J Pharm Pharmacol (1969) 1.18
Cardiovascular effects and interaction with adrenoceptors of urapidil. Arch Int Pharmacodyn Ther (1985) 1.18
Acute hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery. Eur J Pharmacol (1967) 1.17
Characterization of alpha-adrenoceptors participating in the central hypotensive and sedative effects of clonidine using yohimbine, rauwolscine and corynanthine. Eur J Pharmacol (1981) 1.17
The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives. J Med Chem (1990) 1.17
[On the problem of binding of H3-digoxin by myocardial tissue]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 1.12
Influence of tramadol on neurotransmitter systems of the rat brain. Arzneimittelforschung (1996) 1.12
Aconitum sp. alkaloids: the modulation of voltage-dependent Na+ channels, toxicity and antinociceptive properties. Eur J Pharmacol (1997) 1.10
Ocular penetration of beta-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol. Doc Ophthalmol (1980) 1.10
Proximal nephron and renal effects of DuP 753, a nonpeptide angiotensin II receptor antagonist. Kidney Int (1990) 1.10
Identification of vascular postsynaptic alpha 1- and alpha 2-adrenoceptors in man. Circ Res (1984) 1.09
Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther (1990) 1.08
The interaction between prazosin and clonidine at alpha-adrenoceptors in rats and cats. Eur J Pharmacol (1979) 1.08
Penetration of atenolol in the rabbit eye. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1978) 1.08
Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X. Hypertension (1990) 1.07
Treating urinary incontinence in the elderly--conservative therapies that work: a systematic review. J Fam Pract (2004) 1.07
Effect of converting enzyme inhibition and angiotensin receptor blockade on the vasoconstriction mediated by alpha 1-and alpha 2-adrenoceptor stimulation in pithed normotensive rats. Naunyn Schmiedebergs Arch Pharmacol (1982) 1.06
CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences. Eur J Clin Pharmacol (1999) 1.06
Central hypotensive effect of alpha-methyldopa. J Pharm Pharmacol (1968) 1.04
The influence of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride (clonidine) and some related compounds on gastric secretion in the anaesthetized rat. Eur J Pharmacol (1970) 1.04
Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil. J Cardiovasc Pharmacol (1988) 1.03
Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo. Biochem Biophys Res Commun (1989) 1.03
Lipophilicity and brain disposition of clonidine and structurally related imidazolidines. Naunyn Schmiedebergs Arch Pharmacol (1977) 1.03
Modulation of noradrenaline release by peripheral presynaptic alpha 2-adrenoceptors in humans. J Cardiovasc Pharmacol (1987) 1.01
Proposed update of angiotensin receptor nomenclature. Hypertension (1995) 1.01
A lipophilic, selective alpha1 -adrenoceptor agonist: 2-(2-chloro-5-trifluoromethylphenylimino)imida-zolidine (St 587). Life Sci (1981) 1.00
[Calcium content of the myocardium in acute hypothermia]. Anaesthesist (1966) 0.99
Regional vascular effects of serotonin and ketanserin in young, healthy subjects. Hypertension (1988) 0.99
Pharmacology of nonpeptide angiotensin II receptor antagonists. Annu Rev Pharmacol Toxicol (1992) 0.98
Organic and inorganic calcium antagonists reduce vasoconstriction in vivo mediated by postsynaptic alpha 2-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.98
Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II. Circulation (1991) 0.98
Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol, and their enantiomers. Cardiovasc Res (1974) 0.98
Participation of cardiac presynaptic alpha 2-adrenoceptors in the bradycardiac effects of clonidine and analogues. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.97
Relationship between phosphatidylinositol turnover and Ca++ mobilization induced by alpha-1 adrenoceptor stimulation in the rat aorta. J Pharmacol Exp Ther (1987) 0.96
Orthostatic hypotension due to suppression of vasomotor outflow after amphetamine intoxication. Mayo Clin Proc (1996) 0.95
Centrally mediated hypotensive activity of B-HT 933 upon infusion via the cat's vertebral artery. Pharmacology (1980) 0.94
Discovery of an orally active series of isoxazoline glycoprotein IIb/IIIa antagonists. J Med Chem (1997) 0.94
Hemodynamic characterization of pinacidil in rats. Comparison with hydralazine. Pharmacology (1983) 0.94
Extrasynaptic location of alpha-2 and noninnervated beta-2 adrenoceptors in the vascular system of the pithed normotensive rat. J Pharmacol Exp Ther (1982) 0.93
Calcium metabolism in atrial tissue during frequency potentiation and paired stimulation. Pflugers Arch (1970) 0.93
Nonpeptide angiotensin II receptor antagonists. Studies with EXP9270 and DuP 753. Hypertension (1990) 0.93
Effect of angiotensin II antagonism on canine renal sympathetic nerve function. Hypertension (1991) 0.92
The contractions induced in rat and guinea-pig aortic strips by the alpha 2-adrenoceptor selective agonists B-HT 920 and UK 14,304 are mediated by alpha 1-adrenoceptors. Eur J Pharmacol (1984) 0.92